Clinical Trial Update: Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating hepatic arterial infusion of autologous tumor-infiltrating lymphocytes in patients with metastatic melanoma to the liver.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Uveal Melanoma

Drugs mentioned

• Autologous tumor infiltrating lymphocytes (TILs)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma | Phase 1 | Status: COMPLETED